Novartis Pharmaceuticals

Novartis is caring and curing. We are committed to research and development and since 2007 Novartis has invested 20% of its net pharmaceutical sales globally in R&D – in Australia we invest around $AUD 30 million annually. Our dedication to research drives innovation and we have one of the strongest pipelines in the industry. In Australia, the Novartis Group comprises of – Alcon, Novartis Pharmaceuticals and Sandoz. To find out more about who Novartis is, visit www.novartis.com.au  

Show On Map